Streetbeat News

NSRGY

Nestle SA

https://www.nestle.com/

CEO

Ulf Schneider

Open

99.26

Mkt cap

260B

Volume

49K

High

101.13

P/E Ratio

21.28

52-wk high

110.46

Low

99.07

Div yield

0.03

52-wk low

80.11

The article discusses the idea of making the day after the Super Bowl a national holiday, citing a significant number of people who miss work and the potential productivity loss. It mentions Paramount Inc (NASDAQ:PARA)(NASDAQ:PARAA) broadcasting Super Bowl LVIII and Nestle (OTC:NSRGY) through its joint venture Drumstick, advocating for the holiday with a Super Bowl commercial. NFL Commissioner Roger Goodell's stance on keeping the game on Sunday for larger audiences is also highlighted.

Portfolio Pulse from Chris Katje

February 11, 2024 | 2:28 pm

Codexis, Inc. (CDXS) has entered into a purchase agreement with Nestlé Health Science, a division of Nestlé S.A. (NSRGY), for the enzyme CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI). The deal could be worth up to $45 million in milestone payments for Codexis, including a $5 million upfront payment and additional sales-based royalties. Codexis may receive another $5 million if Nestlé exercises an option for two more early-stage enzymes. Nestlé Health Science will take over the development and marketing of CDX-7108. Following the news, CDXS shares rose by 4.52% to $3.47.

Portfolio Pulse from Akanksha Bakshi

December 27, 2023 | 3:28 pm

Nestle S.A. CEO Mark Schneider stated that the use of weight loss drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy has not affected coffee demand. He sees growth in health science, particularly in 'Active Nutrition,' which is strong in North America and will expand geographically. Nestle aims to innovate for GLP-1 patients' needs, with new launches planned for next year. NSRGY shares dropped slightly by 0.22% to $111.94.

Portfolio Pulse from Nabaparna Bhattacharya

December 20, 2023 | 4:06 pm

Nestlé SA (OTC:NSRGY) plans to develop products that pair with popular weight-loss medications like Ozempic, Wegovy, and Mounjaro. The move comes amid concerns about the potential impacts these appetite-suppressing drugs might have on the food industry. Nestlé's CEO, Mark Schneider, stated that the company's portfolio will not be significantly affected as consumers will continue to consume coffee and pet food, two of the company’s major revenue streams.

Portfolio Pulse from Benzinga Neuro

October 20, 2023 | 9:39 am

Morgan Stanley has outlined industries that could be impacted by the rise of weight-loss drugs like Ozempic and Wegovy. The packaged food industry, including companies like Nestle, Mondelez International, and PepsiCo, could suffer as consumers change their consumption patterns. Fast-food restaurants like McDonald’s and Wendy's could also be negatively impacted, while establishments like Chipotle Mexican Grill and Cava Group could benefit. Plus-size retailers could face challenges, while sportswear companies like Nike could benefit.

Portfolio Pulse from Aaron Bry

October 19, 2023 | 9:30 pm

Nestle SA reported a nine-month FY23 revenue decline of 0.4% Y/Y to $76.7 billion, impacted by foreign currency translations and acquisitions. Organic revenue grew 7.8% Y/Y, with a 9% Y/Y rise in emerging markets. The company bought a majority interest in Grupo CRM and divested its peanut allergy treatment business, Palforzia. Nestle plans to grow the sales of its more nutritious products by CHF 20-25 billion by 2030. The company reiterated its FY23 outlook.

Portfolio Pulse from Lekha Gupta

October 19, 2023 | 1:40 pm

Food and beverage stocks have experienced significant declines, with the First Trust Nasdaq Food & Beverage ETF (FTXG) falling over 5% this week. This is attributed to concerns over weight-loss drugs like Ozempic and Wegovy, manufactured by Novo Nordisk (NVO), which could alter consumption patterns and reduce demand for high-calorie foods and beverages. Walmart (WMT) reported a decline in shopping demand due to these drugs. Bank of America analysts suggest that the highest risk of reduced consumption pertains to alcohol, snacking, non-alcoholic beverages, and weight management products. Several food stocks, including The Hershey Company (HSY), PepsiCo (PEP), and The Coca-Cola Company (KO), are trading lower this week.

Portfolio Pulse from Piero Cingari

October 06, 2023 | 8:01 pm

Arm Holdings is preparing for an IPO that could value the company at $54 billion. Goldman Sachs has dismissed multiple employees due to violations of its communications guidelines. Google is reducing its global recruiting department due to a hiring slowdown. Starbucks founder and former CEO Howard Schultz is leaving the company's board. Marvel Studios' VFX workers have voted for unionization. Singapore may impose new rules on ride-hailing companies like Grab Holdings. Kroger's Home Chef division is in a logo dispute with Grubhub. Carrefour is issuing price alerts on products from suppliers like Nestle, PepsiCo, and Unilever. CrownRock is preparing for a potential sale that could value the company at over $10 billion. Delta Air Lines and United Airlines are facing an antitrust lawsuit. Ron Baron holds over $1 billion in shares in SpaceX. Microsoft is facing a formal EU complaint over its Teams app. Electronic Arts' Stig Asmussen is leaving the company. OpenAI is opening a new office in Dublin. Caesars Entertainment has suffered a cybersecurity breach.

Portfolio Pulse from Vandana Singh

September 14, 2023 | 1:56 pm

French supermarket Carrefour has issued price alerts on several products from suppliers such as Nestle, PepsiCo, and Unilever, in a bid to combat inflation. The move comes ahead of contract negotiations and aims to pressure these companies into reducing their prices. Carrefour has labelled 26 products in its French stores, indicating that their volume or weight has decreased while their prices have increased. The French Finance Minister supports this initiative and has urged major retailers and consumer groups to lower prices.

Portfolio Pulse from Vandana Singh

September 14, 2023 | 11:34 am

Nestle S.A. (OTC:NSRGY) has agreed to buy a majority stake in Brazilian premium chocolate company Grupo CRM from Advent International. The deal, estimated to be worth between $602.78 million and $904.18 million, will enhance Nestle's presence in the high-end gifting segment. The transaction is expected to close in 2024, subject to regulatory approvals.

Portfolio Pulse from Lekha Gupta

September 07, 2023 | 11:09 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.